|
|
|
R E S O L U T I O N
|
|
|
WHEREAS, Prostate cancer is the second most common type of |
|
cancer and the second leading cause of cancer death among American |
|
men; and |
|
WHEREAS, One in every nine men is diagnosed with prostate |
|
cancer over the course of his lifetime, and in 2019, experts |
|
estimate that there will be nearly 175,000 new cases and more than |
|
31,500 deaths from prostate cancer; this year, approximately 10,660 |
|
Texas men are expected to be diagnosed and another 1,900 Texans will |
|
die from the disease; and |
|
WHEREAS, Although prostate cancer affects men of all races |
|
and socioeconomic levels, African Americans are at an increased |
|
risk; overall, African American men are 1.7 times more likely to be |
|
diagnosed with and 2.3 times more likely to die from prostate cancer |
|
than white men; African American men are also slightly more likely |
|
than white men to be diagnosed with advanced stages of the disease, |
|
which coincide with a far less optimistic prognosis; and |
|
WHEREAS, Early detection and treatment offer prostate cancer |
|
patients the best hope for a full recovery, and improving patient |
|
outcomes depends a great deal on increasing public awareness of |
|
prostate cancer and its risk factors; men are advised to consult |
|
with their physicians to assess their individual risk of developing |
|
prostate cancer and to determine whether screenings and other tests |
|
are appropriate; and |
|
WHEREAS, Additional focus is needed on the personal and |
|
social burdens of prostate cancer in order to provide patients, |
|
their families, and their caregivers the support they require; |
|
individuals diagnosed with prostate cancer can benefit from |
|
learning about the disease from health care providers, as well as |
|
from taking advantage of support groups and other resources to help |
|
them better cope with their illness and treatment process; and |
|
WHEREAS, There are more scientific studies to be done to keep |
|
the medical community on the leading edge of prostate cancer |
|
treatments, and the observance of Prostate Cancer Awareness Month |
|
in September is an opportunity for the State of Texas to affirm its |
|
commitment to prostate cancer research as a priority of great |
|
importance; now, therefore, be it |
|
RESOLVED, That the House of Representatives of the 86th Texas |
|
Legislature hereby recognize September 2019 as Prostate Cancer |
|
Awareness Month and encourage Texans to seek out more information |
|
about prostate cancer. |
|
|
Dutton |
|
|
|
______________________________ |
|
Speaker of the House |
|
|
I certify that H.R. No. 479 was adopted by the House on March |
|
13, 2019, by a non-record vote. |
|
|
|
______________________________ |
|
Chief Clerk of the House |
|